The National Academies Testimony before Congress

Public Laws Containing Studies for the National Academies

Briefings to Congress

Congressionally Mandated Reports

Policy Statements and Historical Documents

The OCGA staff

THE NATIONAL ACADEMIES
Institute of Medicine
Medical Follow-Up Agency
Committee to Assess the Safety and Efficacy of hte Anthrax Vaccine

*****

Congressional Briefings
Tuesday, March 5, 2002
418 Russell Senate Office Bldg. -- 2:00 p.m.
and
2325 Rayburn House Office Bldg. -- 4:00 p.m.

on

The Anthrax Vaccine: Is It Safe? Does It Work?

Requested by Congress in PL106-79, this new report from the Institute of Medicine gives findings and recommendations to the U.S. Department of Defense on the safety and efficacy of the licensed anthrax vaccine. Issues discussed in the report include adverse reactions, gender differences in reactions, long-term health implications, effectiveness against inhalational exposure, and the correlation of animal models to safety and effectiveness in humans. The study also addresses aspects of the manufacturing process, the definition of vaccine components in terms of the protective antigen and other bacterial products, and identifies gaps in existing research.

These series of briefings were for members of Congress and congressional staff only. The report was publicly released on March 6, 2002. The full text can be found on the Web site of the National Academies Press.